Porvair plc (LSE: PRV) has quietly become one of the more acquisitive names among UK small-cap industrials. In six months the specialist filtration and laboratory technology group has signed three deals, one per division, for roughly £25m in aggregate, while reporting record first-half Revenue and profit on 29 June 2026.

The question is whether this step-up in deal-making, which has taken the group from £22.9m of cash at the end of November 2025 to £7.1m of net cash at 31 May 2026, can sustain the growth record without stretching a Business that has historically preferred small bolt-ons. With a nine-month trading update due in September and a Capital Markets event on 14 October 2026, answers should come soon.

Interim results: record first half as acquisitions add scale

Porvair (LSE:PRV)'s interim results for the six months to 31 May 2026, published on 29 June 2026, showed revenue up 9% to £106.2m (H1 2025: £97.7m) and adjusted operating profit up 10% to £13.8m (H1 2025: £12.6m). Reported profit before tax rose 6% to £12.0m and adjusted Basic Earnings Per Share climbed 11% to 22.1p. The Interim Dividend was lifted 9% to 2.4p.

Headline growth flattered the underlying picture: organic constant-currency revenue growth was 2%, with most of the increase coming from Drache Umwelttechnik GmbH, the German aluminium filtration specialist bought in January 2026 for €20.5m (about £17.8m). Drache contributed £7.3m of revenue and £0.8m of operating profit and is trading "slightly ahead of expectations".

Chief executive Hooman Caman Javvi said the group had "delivered both record revenue and profit in the first half, reflecting disciplined execution and the strength and resilience of Porvair (LSE:PRV)'s diversified portfolio against mixed conditions across the Group's end markets". Strength in aerospace, nuclear, life sciences, aluminium and superalloys, he added, was "partially offset by expected weakness in Petrochemicals and certain industrial end markets".

Two further deals accompanied the results: GV Filtri Industriali S.r.l., an Italian industrial filtration business with roughly €5m of 2025 revenue, for €6.7m (about £5.8m, including €1.0m deferred), subject to regulatory approval, and the completed £1.1m purchase of Carekem Limited, a UK laboratory consumables business with £0.8m of annual revenue. The board said full-year expectations were "unchanged", excluding part-year contributions from GV and Carekem. On 1 September 2026 the company also announced Laura Wand, a former Johnson Controls executive, as a non-executive director from 1 October 2026.

What Porvair does

Listed on the London Stock Exchange since 1988, Porvair designs and manufactures filtration, separation and analytical products for demanding applications. Aerospace & Industrial supplies filters and equipment to aircraft, nuclear, petrochemical, gasification and industrial customers. Laboratory, which includes Seal Analytical, sells instruments and consumables for water and environmental testing and life sciences. Metal Melt Quality, now including Drache, makes ceramic filters and consumables that remove impurities from molten aluminium and superalloys.

In the year to 30 November 2025, the Americas accounted for 44% of revenue, Continental Europe 27%, Asia 16%, the UK 11% and Africa 2%. Management argues that plants mainly serving local customers insulate the group from Tariff and geopolitical disruption, and consumables provide recurring Demand once a product is specified.

Financial performance: margins edging higher

The first half builds on a solid 2025. For the year to 30 November 2025, revenue rose 1% to £194.0m (2% at constant currency), adjusted operating profit increased 7% to £26.2m, profit before tax rose 11% to £23.3m and adjusted earnings per share grew 10% to 42.3p. The dividend was raised 6% to 6.7p and the group closed the year with £22.9m of cash.

In the six months to 31 May 2026, the adjusted operating Margin edged up to 13.0% and return on capital employed to 14.0%. Laboratory delivered the best margin progress, with adjusted operating profit up 9% to £5.0m on revenue of £33.2m and a 15.1% margin. Metal Melt Quality grew revenue 40% to £29.3m (10% organically at constant currency) and profit 39% to £4.6m. Aerospace & Industrial lagged, with revenue down 2% to £43.8m and profit down 6% to £6.1m, as petrochemical sales fell by around £7m against a strong comparator, only partly offset by 8% growth in aerospace.

Cash from operations was £9.7m (H1 2025: £10.2m) after a seasonal £5.8m Working Capital build. Total Investment of £21.2m, including £4.0m of Capital Expenditure and the Drache purchase, took net cash to £7.1m from £17.1m a year earlier, with £8.3m of borrowings drawn. Over ten years, revenue has compounded at 7% a year and adjusted earnings per share at 10%.

At 870p on 2 September 2026, according to lse.co.uk, the shares sit below their 52-week high of 920p, reached on 12 January 2026 when the Drache deal was announced, and above a March low of 684p, for a Market Capitalisation of around £402m.

What could drive the stock next

The most immediate catalyst is the nine-month trading update; last year's arrived on 16 September. Investors will look for confirmation that full-year expectations remain intact and for any comment on petrochemical demand. The capital markets event on 14 October 2026 will showcase all three divisions and the priorities of Mr Caman Javvi, chief executive since January 2025.

Completion of the GV Filtri acquisition, still awaiting regulatory approval at the end of June, would add an Italian base for Aerospace & Industrial. Drache's integration is progressing to plan, and the newly completed £5.5m aluminium cast house at Hendersonville should support Metal Melt Quality's product development. Further out, management cites tightening environmental regulation, growth in analytical science, clean water demand and the substitution of aluminium for heavier materials in transport as structural drivers.

Risks investors should watch

The obvious near-term concern is Aerospace & Industrial, where petrochemical demand has been weak and operational gearing has compressed margins. Laboratory also flagged early signs of possible moderation in environmental testing demand in the second half of 2026. Organic growth of 2% is modest, so headline expansion now depends on acquisitions performing as planned, with the integration and valuation risk that entails, while net cash has fallen to £7.1m and borrowings are drawn.

Currency matters too: with 89% of revenue generated outside the UK, sterling strength reduces reported figures. Management has flagged geopolitical uncertainty in the Middle East, though it says local Manufacturing limits exposure. With a Market Value near £400m and modest daily volumes, Liquidity in the shares can also be thin.

Outlook

Porvair enters the final quarter of its financial year with a record first half, unchanged guidance and three acquisitions to integrate. The September trading update will show whether the petrochemical drag is stabilising and Laboratory demand holding, while the October capital markets event should clarify how far management intends to push the acquisition-led strategy. For a company long known for incremental progress, the coming months will test whether a faster pace of deal-making can deliver the same consistency.